Cargando…
Correction: Phase I Trial of ALRN-6924, a Dual Inhibitor of MDMX and MDM2, in Patients with Solid Tumors and Lymphomas Bearing Wild-type TP53
| Autores principales: | , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Association for Cancer Research
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10361214/ https://www.ncbi.nlm.nih.gov/pubmed/35045962 http://dx.doi.org/10.1158/1078-0432.CCR-21-4241 |
| _version_ | 1785076169467494400 |
|---|---|
| author | Saleh, Mansoor N. Patel, Manish R. Bauer, Todd M. Goel, Sanjay Falchook, Gerald S. Shapiro, Geoffrey I. Chung, Ki Y. Infante, Jeffrey R. Conry, Robert M. Rabinowits, Guilherme Hong, David S. Wang, Judy S. Steidl, Ulrich Walensky, Loren D. Naik, Gurudatta Guerlavais, Vincent Vukovic, Vojislav Annis, D. Allen Aivado, Manuel Meric-Bernstam, Funda |
| author_facet | Saleh, Mansoor N. Patel, Manish R. Bauer, Todd M. Goel, Sanjay Falchook, Gerald S. Shapiro, Geoffrey I. Chung, Ki Y. Infante, Jeffrey R. Conry, Robert M. Rabinowits, Guilherme Hong, David S. Wang, Judy S. Steidl, Ulrich Walensky, Loren D. Naik, Gurudatta Guerlavais, Vincent Vukovic, Vojislav Annis, D. Allen Aivado, Manuel Meric-Bernstam, Funda |
| author_sort | Saleh, Mansoor N. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10361214 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | American Association for Cancer Research |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-103612142023-07-22 Correction: Phase I Trial of ALRN-6924, a Dual Inhibitor of MDMX and MDM2, in Patients with Solid Tumors and Lymphomas Bearing Wild-type TP53 Saleh, Mansoor N. Patel, Manish R. Bauer, Todd M. Goel, Sanjay Falchook, Gerald S. Shapiro, Geoffrey I. Chung, Ki Y. Infante, Jeffrey R. Conry, Robert M. Rabinowits, Guilherme Hong, David S. Wang, Judy S. Steidl, Ulrich Walensky, Loren D. Naik, Gurudatta Guerlavais, Vincent Vukovic, Vojislav Annis, D. Allen Aivado, Manuel Meric-Bernstam, Funda Clin Cancer Res Corrections American Association for Cancer Research 2022-01-15 2022-01-19 /pmc/articles/PMC10361214/ /pubmed/35045962 http://dx.doi.org/10.1158/1078-0432.CCR-21-4241 Text en ©2022 The Authors; Published by the American Association for Cancer Research https://creativecommons.org/licenses/by/4.0/This open access article is distributed under the Creative Commons Attribution 4.0 International (CC BY 4.0) license. |
| spellingShingle | Corrections Saleh, Mansoor N. Patel, Manish R. Bauer, Todd M. Goel, Sanjay Falchook, Gerald S. Shapiro, Geoffrey I. Chung, Ki Y. Infante, Jeffrey R. Conry, Robert M. Rabinowits, Guilherme Hong, David S. Wang, Judy S. Steidl, Ulrich Walensky, Loren D. Naik, Gurudatta Guerlavais, Vincent Vukovic, Vojislav Annis, D. Allen Aivado, Manuel Meric-Bernstam, Funda Correction: Phase I Trial of ALRN-6924, a Dual Inhibitor of MDMX and MDM2, in Patients with Solid Tumors and Lymphomas Bearing Wild-type TP53 |
| title | Correction: Phase I Trial of ALRN-6924, a Dual Inhibitor of MDMX and MDM2, in Patients with Solid Tumors and Lymphomas Bearing Wild-type TP53 |
| title_full | Correction: Phase I Trial of ALRN-6924, a Dual Inhibitor of MDMX and MDM2, in Patients with Solid Tumors and Lymphomas Bearing Wild-type TP53 |
| title_fullStr | Correction: Phase I Trial of ALRN-6924, a Dual Inhibitor of MDMX and MDM2, in Patients with Solid Tumors and Lymphomas Bearing Wild-type TP53 |
| title_full_unstemmed | Correction: Phase I Trial of ALRN-6924, a Dual Inhibitor of MDMX and MDM2, in Patients with Solid Tumors and Lymphomas Bearing Wild-type TP53 |
| title_short | Correction: Phase I Trial of ALRN-6924, a Dual Inhibitor of MDMX and MDM2, in Patients with Solid Tumors and Lymphomas Bearing Wild-type TP53 |
| title_sort | correction: phase i trial of alrn-6924, a dual inhibitor of mdmx and mdm2, in patients with solid tumors and lymphomas bearing wild-type tp53 |
| topic | Corrections |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10361214/ https://www.ncbi.nlm.nih.gov/pubmed/35045962 http://dx.doi.org/10.1158/1078-0432.CCR-21-4241 |
| work_keys_str_mv | AT salehmansoorn correctionphaseitrialofalrn6924adualinhibitorofmdmxandmdm2inpatientswithsolidtumorsandlymphomasbearingwildtypetp53 AT patelmanishr correctionphaseitrialofalrn6924adualinhibitorofmdmxandmdm2inpatientswithsolidtumorsandlymphomasbearingwildtypetp53 AT bauertoddm correctionphaseitrialofalrn6924adualinhibitorofmdmxandmdm2inpatientswithsolidtumorsandlymphomasbearingwildtypetp53 AT goelsanjay correctionphaseitrialofalrn6924adualinhibitorofmdmxandmdm2inpatientswithsolidtumorsandlymphomasbearingwildtypetp53 AT falchookgeralds correctionphaseitrialofalrn6924adualinhibitorofmdmxandmdm2inpatientswithsolidtumorsandlymphomasbearingwildtypetp53 AT shapirogeoffreyi correctionphaseitrialofalrn6924adualinhibitorofmdmxandmdm2inpatientswithsolidtumorsandlymphomasbearingwildtypetp53 AT chungkiy correctionphaseitrialofalrn6924adualinhibitorofmdmxandmdm2inpatientswithsolidtumorsandlymphomasbearingwildtypetp53 AT infantejeffreyr correctionphaseitrialofalrn6924adualinhibitorofmdmxandmdm2inpatientswithsolidtumorsandlymphomasbearingwildtypetp53 AT conryrobertm correctionphaseitrialofalrn6924adualinhibitorofmdmxandmdm2inpatientswithsolidtumorsandlymphomasbearingwildtypetp53 AT rabinowitsguilherme correctionphaseitrialofalrn6924adualinhibitorofmdmxandmdm2inpatientswithsolidtumorsandlymphomasbearingwildtypetp53 AT hongdavids correctionphaseitrialofalrn6924adualinhibitorofmdmxandmdm2inpatientswithsolidtumorsandlymphomasbearingwildtypetp53 AT wangjudys correctionphaseitrialofalrn6924adualinhibitorofmdmxandmdm2inpatientswithsolidtumorsandlymphomasbearingwildtypetp53 AT steidlulrich correctionphaseitrialofalrn6924adualinhibitorofmdmxandmdm2inpatientswithsolidtumorsandlymphomasbearingwildtypetp53 AT walenskylorend correctionphaseitrialofalrn6924adualinhibitorofmdmxandmdm2inpatientswithsolidtumorsandlymphomasbearingwildtypetp53 AT naikgurudatta correctionphaseitrialofalrn6924adualinhibitorofmdmxandmdm2inpatientswithsolidtumorsandlymphomasbearingwildtypetp53 AT guerlavaisvincent correctionphaseitrialofalrn6924adualinhibitorofmdmxandmdm2inpatientswithsolidtumorsandlymphomasbearingwildtypetp53 AT vukovicvojislav correctionphaseitrialofalrn6924adualinhibitorofmdmxandmdm2inpatientswithsolidtumorsandlymphomasbearingwildtypetp53 AT annisdallen correctionphaseitrialofalrn6924adualinhibitorofmdmxandmdm2inpatientswithsolidtumorsandlymphomasbearingwildtypetp53 AT aivadomanuel correctionphaseitrialofalrn6924adualinhibitorofmdmxandmdm2inpatientswithsolidtumorsandlymphomasbearingwildtypetp53 AT mericbernstamfunda correctionphaseitrialofalrn6924adualinhibitorofmdmxandmdm2inpatientswithsolidtumorsandlymphomasbearingwildtypetp53 |